SEAN HUIRAS: Open Payments
NPI 1225078074 · RICHMOND, VA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$563 in 20 payments from 10 companies in 2025. Trend: 2023 $490 · 2024 $725 · 2025 $563
Food & beverage: $563
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 6 | $168 |
| Merck Sharp & Dohme LLC | 3 | $84 |
| Eisai Inc. | 3 | $76 |
| Davol Inc. | 1 | $49 |
| Fennec Pharmaceuticals, Inc. | 2 | $36 |
| GlaxoSmithKline, LLC. | 1 | $34 |
| AstraZeneca Pharmaceuticals LP | 1 | $32 |
| Novartis Pharmaceuticals Corporation | 1 | $30 |
| Daiichi Sankyo Inc. | 1 | $29 |
| Teleflex LLC | 1 | $25 |
Products named: ELAHERE, Lenvima, LYNPARZA, KEYTRUDA, ARISTA, Fyarro, JEMPERLI, KISQALI.
Industry payments across VA — which companies pay providers there.
